Studies have indicated that the JAK1/STAT1 signaling pathway modulates inflammation and left ventricular remodeling post-myocardial infarction, thereby mitigating myocardial I/R injury in cardiac tissues and cardiomyocytes (Zhang et al. 2023a, b). This evidence concerns the gene JAK1 and myocardial infarction.